BlueRock Therapeutics società ha sostenuto
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
leggi di più
It has been a great experience so far, exciting!
Quali sono alcune delle cose migliori della tuo team?
It is transparent and we all work well together.
La cosa più positiva della cultura e l'ambiente presso la tua azienda?
It is exciting and amazing therapeutics in the pipeline.
Che cosa ti rende più felice sul posto di lavoro?
Being part of something new an exciting in the therapeutic area for patients.
Cosa ti piace di più del team di leadership?
They are clear in their vision and focused on gathering the right talent to move the organization from research to a pre-commercial.
Other Employee Reviews for BlueRock Therapeutics
×